| LIQUIDITY AND GOING CONCERN CONSIDERATIONS | NOTE
2 – LIQUIDITY AND GOING CONCERN CONSIDERATIONS At
June 30, 2017, the Company’s total current liabilities of $48.6 million exceeded its total current assets of $2.4 million,
resulting in a working capital deficit of $46.2 million, while at March 31, 2017, the Company’s total current liabilities
of $48.2 million exceeded its total current assets of $3.9 million, resulting in a working capital deficit of $44.3 million. The
$1.9 million increase in the working capital deficit is primarily due to our loss from operations and interest payments of $0.6
million. The
Company has entered into the following transactions to address liquidity and going concern issues: Vantage
Agreement On
August 2, 2017, and effective June 13, 2017, the Company entered into an agreement with Vantage Fund, LLC (“Vantage”
and the “Vantage Agreement”), pursuant to which Vantage agreed to provide up to $6 million of funding to the Company,
in the sole discretion of Vantage, with $400,000 provided in the initial tranche (the “Initial Tranche”). The consideration
for the Initial Tranche of funding was the assignment to Vantage of all of the Company’s rights and ownership in its wholly-owned
subsidiary Camber Permian II, LLC (“Camber Permian”) which included leaseholds and potential participation rights.
The Vantage Agreement contained customary indemnification requirements. Vantage
also had the right pursuant to the Vantage Agreement to fund up to $300,000 of additional funding in the form of a convertible
promissory note, secured by a second lien on the Company’s Jackrabbit project (the “Vantage Note”). The Vantage
Note was to be subject to mutually acceptable terms, provided that such note would have a term of no more than 2 years, an annual
interest rate of no less than 6% per annum, and a conversion price equal to the closing price of the Company’s common stock
on the day prior to funding. If funded, an additional condition to the Vantage Note was that Vantage or its assigns would have
the right to acquire the Jackrabbit project at market price and a right of first refusal to purchase the Jackrabbit project upon
any sale thereof. Vantage has subsequently determined not to fund the Vantage Note or to provide the Company any further funding
other than the Initial Tranche. The
Company agreed to grant Vantage three-year warrants to purchase shares of common stock in connection with any funding, equal to
the equivalent value of warrants (i.e., equal to the amount of funding provided), plus 20%, with an exercise price equal to the
closing price of the Company’s common stock on the day immediately prior to funding. In connection with the funding of the
Initial Tranche, which occurred on August 2, 2017, the Company granted Vantage warrants to purchase 1,600,000 shares of common
stock with an exercise price of $0.25 per share (the “Vantage Warrants”). The Company also agreed to register any
of the shares issued upon exercise of the Vantage Warrants under the Securities Act of 1933, as amended, within 30 days from the
date of exercise thereof. On
August 2, 2017, and effective June 13, 2017, Vantage provided the Company the Initial Tranche funding, in exchange, the Company
assigned all of our rights in Camber Permian to Vantage pursuant to an Assignment, and granted Vantage the warrants to purchase
1,600,000 shares of common stock effective June 13, 2017. On
July 17, 2017, Vantage provided $120,000 to the Company under the Vantage Note and on July 20, 2017, Vantage provided $30,000
to the Company under the Vantage Note. Vantage was granted a second lien on the Jackrabbit property in connection with the financing. Stock
and Securities Purchase Agreements with Institutional Investor On
April 6, 2016, the Company entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with
an accredited institutional investor (the “Investor”), pursuant to which we sold and issued a redeemable convertible
subordinated debenture, with a face amount of $530,000, initially convertible into 163,077 shares of common stock (subject to
certain conversion premiums) at a conversion price equal to $3.25 per share and a warrant to initially purchase 1,384,616 shares
of common stock (subject to adjustment thereunder) at an exercise price equal to $3.25 per share (the “First Warrant”).
The Investor purchased the debenture at a 5.0% original issue discount in the amount of $500,000 and has exercised the First Warrant
in full as described below for the sum of $4.5 million. Also
on April 6, 2016, the Company entered into a Stock Purchase Agreement with the Investor, pursuant to which we agreed, subject
to certain conditions, to issue up to 527 shares of Series C redeemable convertible preferred stock (the “Series C Preferred
Stock”) at a 5% original issue discount, convertible into 1,618,462 shares of common stock (subject to certain conversion
premiums) at a conversion price of $3.25 per share, and a warrant to initially purchase 1,111,112 shares of common stock at an
exercise price of $4.50 per share (the “Second Warrant”). Under the terms of the Stock Purchase Agreement, the Second
Warrant and 53 shares of Series C Preferred Stock were sold and issued for $500,000 on September 2, 2016, and the remaining 474
shares of Series C Preferred Stock were sold and issued for $4.5 million on November 17, 2016. On
October 7, 2016, the Investor exercised the First Warrant in full and was due 1,384,616 shares of common stock upon exercise thereof
and an additional 2,542,735 shares of common stock in consideration for the conversion premium due thereon. A total of 810,000
shares were issued to the Investor on October 7, 2016, with the remaining shares being held in abeyance until such time as it
would not result in the Investor exceeding its beneficial ownership limitation (4.99% of the Company’s outstanding common
stock). The Company received gross proceeds of $4,500,000 from the exercise of the First Warrant and paid placement agent fees
of $427,500 for services rendered in connection with the First Warrant. Pursuant to the terms of the First Warrant, the number
of shares due in consideration for the conversion premium increases as the annual rate of return under the First Warrant increases,
including by 10% upon the occurrence of certain triggering events (which had occurred by the October 7, 2016 date of exercise),
to 17% per annum upon the exercise of the First Warrant. Additionally, as the conversion rate for the conversion premium is currently
85% of the lowest daily volume weighted average price during the measuring period, less $0.10 per share of common stock not to
exceed 85% of the lowest sales prices on the last day of such period less $0.10 per share, the number of shares issuable in connection
with the conversion premium increases as the trading price of our common stock decreases, and the trading price of our common
stock has decreased since the date the First Warrant was exercised, triggering a further reduction in the conversion price of
the conversion premium and an increase in the number of shares due to the Investor in connection with the conversion of the amount
owed in connection with the conversion premium. Additionally, pursuant to the interpretation of the Investor, the measurement
period for the calculation of the lowest daily volume weighted average price currently continues indefinitely. On
October 5, 2017, the Company and the Investor entered into a Stock Purchase Agreement (the “October 2017 Purchase Agreement”),
pursuant to which the Company may receive aggregate consideration of $16 million, subject to certain conditions set forth therein. Under
the terms of the October 2017 Purchase Agreement, (1) the Investor purchased 212 shares of Series C Preferred Stock on the closing
date of the agreement, October 4, 2017 (the “Initial Closing”), for $2 million, and agreed, subject to certain closing
conditions set forth in the agreement, to purchase (2) 106 shares of Series C Preferred Stock for $1,000,000, 10 days after the
Initial Closing; (3) 105 shares of Series C Preferred Stock for $1,000,000, 10 days after the second closing; (4) 105 shares of
Series C Preferred Stock for $1,000,000, 10 days after the third closing; (5) 105 shares of Series C Preferred Stock for $1,000,000,
10 days after the fourth closing; (6) 525 shares of Series C Preferred Stock for $5,000,000, 30 days after the fifth closing;
and (7) 525 shares of Series C Preferred Stock for $5,000,000, 30 days after the sixth Closing. Conditions to closing the sale
of the additional shares of Series C Preferred Stock described above include, that except with regard to the first four closings
described above, the Company’s common stock is required to be listed for and currently trading on the NYSE American market
or a higher trading market; the Company is required to be in compliance with all requirements to maintain such listing and there
cannot be any notice of any suspension or delisting with respect to the trading of the shares of common stock on such trading
market; except with regard to the first four closings only, the Company is required to have duly authorized shares of common stock
reserved for issuance to Investor in an amount equal to three times the number of shares sufficient to immediately issue all shares
of common stock potentially issuable upon conversion of the Series C Preferred Stock sold to Investor under the October 2017 Purchase
Agreement (collectively, the “Conversion Shares”) and any other agreements with Investor; except with regard to the
initial closing only, the Company is required to obtain approval and listing of all Conversion Shares on the NYSE American; for
the second through fifth closings only, (i) an aggregate dollar trading volume of at least $10 million must have traded on NYSE
American during regular trading hours, from the trading day after the immediately prior closing until the trading day immediately
before the relevant closing, but expressly excluding all volume traded on any days that the Investor is prevented or delayed from
reselling shares of common stock (“Excluded Days”); and (ii) the Company’s common stock is required to have
a volume weighted average price on the NYSE American for the prior trading day of at least $0.15 per share of common stock; and
with respect to the final two closings, an aggregate dollar trading volume of at least $50 million must have traded on NYSE American
during regular trading hours, from the trading day after the immediately prior closing until the trading day immediately before
the relevant closing, but expressly excluding all volume traded on any Excluded Days, and if any such conditions are not met on
the date initially set for such closing, each closing will occur as soon thereafter as they are met, if ever. The closing of the
additional sales of Series C Preferred Stock as described above are subject to closing conditions which may not be met timely,
if at all, and as such, we may not ever sell any additional shares of Series C Preferred Stock under the October 2017 Purchase
Agreement after the Initial Closing. The
Company plans to use the proceeds from the sale of the Series C Preferred Stock for working capital, workovers on existing wells,
drilling and completion of additional wells, repayment of vendor balances and payments to International Bank of Commerce (“IBC”),
in anticipation of regaining compliance. Pursuant
to the October 2017 Purchase Agreement, as long as the Investor holds any shares of Series C Preferred Stock, the Company agreed
that it would not issue or enter into or amend an agreement pursuant to which it may issue any shares of common stock, other than
(a) for restricted securities with no registration rights, (b) in connection with a strategic acquisition, (c) in an underwritten
public offering, or (d) at a fixed price; or issue or amend any debt or equity securities convertible into, exchangeable or exercisable
for, or including the right to receive, shares of common stock (a) at a conversion price, exercise price or exchange rate or other
price that is based upon or varies with, the trading prices of or quotations for the shares of common stock at any time after
the initial issuance of the security or (b) with a conversion, exercise or exchange price that is subject to being reset at some
future date after the initial issuance of the security or upon the occurrence of specified or contingent events directly or indirectly
related to the business of the Company or the market for the common stock. Additionally,
provided that the Company has not materially breached the terms of the October 2017 Purchase Agreement, it may at any time, in
its sole and absolute discretion, repurchase from Investor all, but not less than all, of the then outstanding shares of Series
C Preferred Stock sold pursuant to the agreement by paying to Investor 110% of the aggregate face value of all such shares. The
Company also agreed to provide the Investor a right of first offer to match any offer for financing we receive from any person
while the shares of Series C Preferred Stock sold pursuant to the October 2017 Purchase Agreement are outstanding, except for
debt financings not convertible into common stock, which are excluded from such right to match. The
conversion premium under the Series C Preferred Stock is payable and the dividend rate under the Series C Preferred Stock is adjustable.
Specifically, the conversion rate of such premiums and dividends equals 95% of the average of the lowest 5 individual daily volume
weighted average prices during the Measuring Period, not to exceed 100% of the lowest sales prices on the last day of the Measuring
Period, less $0.05 per share of common stock, unless a triggering event has occurred, in which case the conversion rate equals
85% of the lowest daily volume weighted average price during the Measuring Period, less $0.10 per share of common stock not to
exceed 85% of the lowest sales prices on the last day of such the Measuring Period, less $0.10 per share. The “Measuring
Period” is the period beginning, if no trigger event has occurred, 30 trading days, and if a trigger event has occurred,
60 trading days, before the applicable notice has been provided regarding the exercise or conversion of the applicable security,
and ending, if no trigger event has occurred, 30 trading days, and if a trigger event has occurred, 60 trading days, after the
applicable number of shares stated in the initial exercise/conversion notice have actually been received into the Investor’s
designated brokerage account in electronic form and fully cleared for trading (subject to certain extensions described in the
applicable securities, which have been triggered to date). Triggering events are described in the designation of the Series C
Preferred Stock, but include items which would typically be events of default under a debt security, including filing of reports
late with the Commission. The
Series C Preferred Stock has a maturity date that is seven years after the date of issuance and, if the Series C Preferred Stock
has not been wholly converted into shares of common stock prior to such date, we may redeem the Series C Preferred Stock on such
date by repaying to the investor in cash 100% of the Face Value plus an amount equal to any accrued but unpaid dividends thereon.
100% of the Face Value, plus an amount equal to any accrued but unpaid dividends thereon, automatically becomes payable in the
event of a liquidation, dissolution or winding up by us. The Company is currently restricted from issuing any other preferred stock (other than the Series B Preferred
Stock) that is pari passu or senior to the Series C Preferred Stock with respect to any rights for a period of one year after
the earlier of such date (i) a registration statement is effective and available for the resale of all shares of common
stock issuable upon conversion of the Series C Preferred Stock, or (ii) Rule 144 under the Securities Act is available for
the immediate unrestricted resale of all shares of common stock issuable upon conversion of the Series C
Preferred Stock. Even
with the Company entering into the October 2017 Purchase Agreement, the Company’s current financial situation raises substantial
doubt about the Company’s ability to continue as a going concern for the next twelve months following the issuance of these
financial statements. The accompanying financial statements have been prepared in accordance with accounting principles generally
accepted in the United States of America on a going concern basis, which contemplates the realization of assets and the satisfaction
of liabilities in the normal course of business. Accordingly, the financial statements do not include any adjustments relating
to the recoverability of assets and classification of liabilities that might be necessary should the Company be unable to continue
as a going concern. Asset
Purchase Agreement On
December 30, 2015, the Company entered into an Asset Purchase Agreement (as amended from time to time the “Asset Purchase
Agreement”) to acquire, from twenty-three different entities and individuals (the “Sellers”), working interests
in producing properties and undeveloped acreage (the “Acquisition”), which acquisition transaction was completed on
August 25, 2016. The assets acquired include varied interests in two largely contiguous acreage blocks in the liquids-rich Mid-Continent
region. In connection with the closing of the acquisition, we assumed approximately $30.6 million of commercial bank debt, issued
13,009,664 shares of common stock to certain of the Sellers, issued 552,000 shares of Series B Preferred Stock to one of the Sellers
and its affiliate, and paid $4,975,000 in cash to certain of the Sellers. The effective date of the Acquisition was April 1, 2016. Pursuant
to a Letter Agreement the Company entered into, at the closing of the Acquisition, RAD2 Minerals, Ltd. (“RAD2”), one
of the Sellers, which is owned and controlled by Richard N. Azar II, who was appointed as the Company’s Chairman on August
26, 2016, serving as Chairman until May 16, 2017, provided that Mr. Azar continues to serve as a member of the Board of Directors
and who was appointed as interim Chief Executive Officer of the Company on June 2, 2017, agreed to accept full financial liability
for any and all deficiencies between the “Agreed Assets Value” set forth in the Asset Purchase Agreement of $80,697,710,
and the mutually agreed upon value of the assets delivered by the Sellers at the closing of the Acquisition, up to an aggregate
of $1,030,941 (as applicable, the “Deficiency”). The Company accepted additional oil and gas producing properties
and two salt water disposal facilities from the Sellers with an approximate value of $1.0 million to resolve this Deficiency.
RAD2 is one of the Sellers, which is owned and controlled by Richard N. Azar II, who was appointed as our Chairman on August 26,
2016, serving as Chairman until May 16, 2017, provided that Mr. Azar continues to serve as a member of the Board of Directors
and who was appointed as interim Chief Executive Officer of the Company on June 2, 2017. The
Asset Purchase Agreement between the Sellers and the Company relating to the Acquisition included the requirement that, following
the closing, the parties undertake an accounting/true-up of expenses attributable to the assets acquired by the Company and revenue
generated from such assets. A dispute has arisen between the Sellers and the Company as to the time period which the Company was
to be responsible for the payment of expenses and was to receive the revenue from such assets prior to the closing of the transaction.
Specifically, the Company believes that the agreements provide for it to be responsible for all expenses associated with the assets,
and to receive all revenue generated from the assets, from April 1, 2016, the effective date of the Asset Purchase Agreement,
through the closing date, August 25, 2016. The Sellers on the other hand, which include entities owned by Richard N. Azar, II,
the Company’s interim Chief Executive Officer, have argued that the Company was only responsible for expenses, and was only
due to receive revenue from the assets, beginning on the closing date, August 25, 2016. The difference in the amounts claimed
due to the Company from the parties currently varies from a high of $1,121,718, which the Company alleges it is due, to a low
of $342,298, which the Sellers allege that the Company is due. The parties continue to discuss the issues raised and to work towards
a mutually acceptable settlement; however, due to the continuing dispute, for the purposes of the attached financial statements,
the Company has recorded a receivable of $1,121,718 with an allowance of $779,420 for a net balance of $342,298. Rogers
Loan and Promissory Note At
June 30, 2017, the Company had $6,866,371 due under the $7.5 million Letter Loan Agreement originally entered into with Louise
H. Rogers (“Rogers”) on August 13, 2013 (the “Rogers Loan”). No amortization of debt discount was recorded
during the three-month periods ending June 30, 2017 and 2016. The
Rogers Loan had a maturity date of July 31, 2017, and the Company agreed to pay all professional fees incurred by Rogers and to
pay Rogers $39,000 in lieu of interest on the Rogers Loan as well as all operating income of collateralized assets (beginning
October 1, 2015). Also, the Company agreed to make principal payments to Rogers from certain insurance proceeds to be received,
which the Company has not received to date. For the months of January, February, March, June and July 2016, the Company did not
make the required monthly principal payments due pursuant to the terms of the Rogers loan as amended. Instead, the Company and
the loan administrator agreed to settle any outstanding administration and legal fees in lieu of the principal payments. The Company
paid approximately $98,000 related to the fees and effective July 5, 2016, and obtained a waiver for the nonpayment of the principal
amounts through July 2016. The Company has not made the $39,000 required monthly fee payments on the Rogers Loan since August
2016, however, the Company has made all required principal payments. Additionally,
per a prior amendment, the Company transferred all of its oil and gas interests and equipment to its then newly formed wholly-owned
Texas subsidiary, CATI Operating LLC, which clarified that following the transfer, Rogers had no right to foreclose upon the Company
(at the Nevada corporate parent level) upon the occurrence of an event of default under the Rogers Loan, and that instead Rogers
would only take action against CATI and its assets and required Rogers to release all UCC and other security filings on the Company
(provided that Rogers is allowed to file the same filings on CATI and its assets). Subsequently, the Company assigned all of its
oil and gas interests and equipment to CATI pursuant to an Assignment and Bill of Sale dated December 16, 2015. On
February 1, 2017, the Company agreed to extend the maturity date of the Rogers Loan from January 31, 2017 to April 30, 2017. As
consideration, the Company paid $9,000 to Rogers and $9,000 to Robertson Global Credit, LLC, the servicer of the loan. In April
2017, the maturity date was extended again until July 31, 2017. As consideration, the Company paid $9,000 to Ms. Rogers and $9,000
to Robertson Global Credit, LLC, the servicer of the loan. The Company failed to pay the amount due to Rogers on July 31, 2017. On
August 25, 2017, the Company received a notice that its wholly-owned subsidiary CATI had defaulted on the maturity payment of
its loan with Rogers, which matured on July 31, 2017. The letter stated that CATI was indebted to Rogers in an amount of $8.9
million, which includes all principal and interest through August 25, 2017. The letter further asserted additional interest of
$3,577 per day as well as other unpaid fees totaling $18,162 plus interest on those fees. The default notice further stated that
the default in failing to pay the fees must be cured by September 5, 2017 and the default on the principal and interest payment
must be cured by September 11, 2017. The
cure period on the Rogers Loan expired on September 11, 2017, and as of such date, all principal, interest and unpaid costs thereunder
were immediately due and payable (which totaled $6.9 million as of June 30, 2017 and approximately $7.1 million as of the date
of acceleration). In September 2017, Rogers foreclosed on the assets of CATI which secured the note. On October 3, 2017, the trustee
of those assets, for the benefit of the lender, sold certain of the assets in public auction foreclosure sales which took place
in Gonzales County and Karnes County, Texas. The proceeds from the foreclosure sales of approximately $3.5 million were applied
against the outstanding indebtedness. The remaining unpaid indebtedness owed by CATI is approximately $3.4 million. CATI is exploring
strategic alternatives related to the remaining owned properties and indebtedness. Loan
Agreement with International Bank of Commerce (“IBC”) As
discussed in “Note 6 – Notes Payable and Debenture”, the Company borrowed $40 million from International Bank
of Commerce (“IBC”) effective August 25, 2016. The proceeds of the loan were used to repay and refinance approximately
$30.6 million of indebtedness owed by certain of the Sellers to IBC as part of the closing of the Acquisition. As of March 31,
2017 and June 30, 2017, the Company was not in compliance with certain covenants of the loan agreement, including requiring the
Company to maintain a net worth of $30 million, and the balance of the loan due to IBC of $37.6 million (less unamortized debt
issuance costs of approximately $2.0 million), was recognized as a short-term liability on the Company’s balance sheet as
of March 31, 2017 and June 30, 2017. The Company also recognized approximately $30,000 in accrued interest as of June 30, 2017
related to this note. On
September 8, 2017, the Company received a Notice of Default and Opportunity to Cure (the “Notice”) from IBC stating
that the Company was in default under its loan with IBC due to failing to make a required $425,000 loan payment on August 25,
2017 (the “Payment Default”). The Notice was also sent to the guarantors under the loan agreement. The Notice also
cited the Company for several covenant defaults including exceeding a cap on monthly general and administrative expenses, falling
below $30 million of net worth, failing to comply with certain post-closing covenants regarding the assignment of certain oil
and gas interests, the execution of certain supplemental mortgages and the completion of certain curative title requirements,
failing to pay costs and expenses required pursuant to the terms of the loan agreement, failing to meet the requirements of a
cash flow test as described in greater detail in the loan agreement, and exceeding the loan to value determination provided for
in the loan agreement. In order to cure the Payment Default described in the Notice, the Company is required to pay $425,000,
as well as any attorney’s fees and/or late fees as determined by IBC, on or before September 18, 2017. The Company has a
30-day cure period under its loan agreement with respect to the covenant defaults. The Company has not cured the defaults and
the entire amount of the IBC loan may be accelerated and IBC may take action to enforce its remedies under the loan agreement.
The IBC loan is secured by substantially all of the Company’s assets and if IBC were to foreclose on our assets it would
have a material adverse effect on our operations and may force us to seek bankruptcy protection. The Company is in discussions
with IBC evaluating its strategic alternatives concerning the defaults. Dreeben
Loan On
March 28, 2016, the Company borrowed $250,000 from Alan Dreeben, one of the Sellers and one of the Company’s then directors,
pursuant to a short-term promissory note. The short-term promissory note has a principal balance of $275,000 (the $250,000 borrowed
plus a $25,000 original issue discount). As additional consideration for Mr. Dreeben agreeing to make the loan, the Company agreed
to issue Mr. Dreeben 15,000 shares of restricted common stock, which were issued in September 2016. The Company recognized a $48,000
discount to the short-term promissory note which was based on the closing price of the Company’s common stock ($3.20 per
share) on March 28, 2016 in addition to the original discount of $25,000, for a total discount of $73,000. On
June 27, 2016, the Company entered into an amended and restated short-term promissory note, amending and restating the note originally
entered into with Mr. Dreeben on March 28, 2016; evidencing an additional $100,000 borrowed on June 13, 2016, plus a $10,000 original
issue discount on such loan amount and extending the maturity date of the note to August 31, 2016. On
August 31, 2016, the Company paid Mr. Dreeben the full amount due on the short-term promissory note of $385,000. On
January 31, 2017, the Company borrowed $1,000,000 from Alan Dreeben, one of the Company’s then directors, pursuant to a
short-term promissory note. The short-term promissory note had a principal balance of $1,050,000 (the $1,000,000 principal amount
borrowed plus a $50,000 original issue discount), accrues interest at 6% per annum and a maturity date of January 31, 2018, with
standard and customary events of default. As additional consideration for Mr. Dreeben agreeing to make the loan, the Company agreed
to issue Mr. Dreeben 40,000 shares of restricted common stock. The 40,000 shares were payable at June 30, 2017 and were subsequently
issued in August 2017. At June 30, 2017, the Company owed $1,050,000 to Alan Dreeben. The fair value of the restricted shares
was $30,000 based on the closing price of the Company’s common stock on the issuance date. The fair value of the shares
was recorded as additional debt discount. The Company also recognized $26,250 in accrued interest as of June 30, 2017. Loan
from Non-Related Individual On
March 9, 2017, the Company borrowed $250,000 from a non-related individual pursuant to a short-term promissory note. The short-term
promissory note has a principal balance of $263,158 (the $250,000 principal amount borrowed plus a $13,158 original issue discount),
accrues interest at 6% per annum and has a maturity date of March 9, 2018 and contains standard and customary events of default.
As additional consideration for agreeing to make the loan, we agreed to issue the lender 10,000 restricted shares of common stock. |
